Universal Health Services Reports Q4 2025 Earnings Miss
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy UHS?
Source: seekingalpha
Universal Health Services Inc. (UHS) experienced a significant decline of 9.63% as it hit a 5-day low amid broader market weakness, with the Nasdaq-100 down 0.95% and the S&P 500 down 0.44%.
The company's Q4 2025 earnings report revealed a non-GAAP EPS of $5.88, which missed analyst expectations by $0.03, raising concerns about profitability. Although revenue grew by 9.1% year-over-year to $4.49 billion, it fell short of market expectations by $20 million, indicating challenges in maintaining growth amid rising costs and competition. This disappointing performance may lead to a reassessment of UHS's future prospects in the healthcare sector.
The market's reaction to the earnings miss reflects a cautious sentiment among investors, as they weigh the implications of UHS's performance against broader economic conditions and industry competition.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UHS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UHS
Wall Street analysts forecast UHS stock price to rise
15 Analyst Rating
7 Buy
7 Hold
1 Sell
Moderate Buy
Current: 206.100
Low
190.00
Averages
248.00
High
302.00
Current: 206.100
Low
190.00
Averages
248.00
High
302.00
About UHS
Universal Health Services, Inc. is a holding company. The Company operates, through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. Its segments include acute care hospital services, behavioral health care services, and Other. It owns and operates approximately 359 inpatient facilities, and 60 outpatient and other facilities located in 39 states, Washington, D.C., the United Kingdom, and Puerto Rico. It provides services, which include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. It also provides capital resources, as well as a variety of management services to its facilities, including information services, finance and control systems, physician recruitment services, and public relations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UNIVERSAL HEALTH SERVICES INC: UBS Increases Target Price from $302 to $320
- Price Increase Announcement: Universal Health Services has raised its target price from $302 to $320.
- Market Impact: This adjustment reflects the company's performance and expectations in the healthcare sector.
See More
Analysis & Outlook: Disappointed with Nvidia
- Market Reaction: Despite strong earnings from Nvidia, stocks experienced a decline.
- Investor Sentiment: The market's response indicates a disconnect between earnings reports and stock performance.
See More
US Stocks Close Mixed: Dow Rises Slightly, Nasdaq Declines
- Mixed Market Performance: On Thursday, the S&P 500 Index fell by 0.54% and the Nasdaq 100 Index declined by 1.16%, while the Dow Jones Industrial Average rose slightly by 0.03%, indicating a divergence in market sentiment, particularly under pressure from tech stocks.
- Nvidia Earnings Impact: Nvidia reported Q4 revenue of $62.3 billion, exceeding expectations, yet its stock dropped over 5% due to uncertainties regarding the Chinese market, reflecting investor concerns about an overheated AI economy that could affect related chipmakers' performance.
- Labor Market Signals: Initial jobless claims in the US rose by 4,000 to 212,000, lower than the expected 216,000, indicating resilience in the labor market, which may provide support for the stock market, especially amid potential interest rate cuts by the Fed.
- Geopolitical Risks Intensify: President Trump threatened military action against Iran, heightening market uncertainty; although there are signs of progress in US-Iran nuclear negotiations, geopolitical risks remain a focal point for investors and could negatively impact the stock market.
See More
U.S. Markets Closed with Mixed Results on Thursday, Driven by IonQ's Performance and Donaldson Co's Underperformance
- U.S. Stock Market Performance: U.S. stock indexes closed mixed on Thursday, with the S&P 500 gaining 0.03%.
- Decline in Other Indexes: The Dow Jones Industrial Average decreased by 0.54%, while the Nasdaq Composite fell by 1.18%.
See More
UHS Reports Strong Q4 2025 Earnings with Strategic Growth Plans
- Significant Revenue Growth: UHS reported a 9% revenue increase in Q4 2025, with adjusted EBITDA net of NCI rising 10% and adjusted EPS up 20%, reflecting strong performance in acute care and behavioral health, thereby enhancing market competitiveness.
- Clear Expansion Plans: The company plans to open three inpatient expansion projects totaling 178 licensed beds in Florida, California, and Nevada, along with a new 156-bed hospital in Palm Beach Gardens, Florida, set to open in Q2 2026, further enhancing service capacity.
- Accelerated Technology Investment: UHS has fully rolled out Agentic AI to improve post-discharge care and reduce readmissions, with plans to introduce new patient safety technologies in 2026, indicating a sustained commitment to technological innovation aimed at enhancing operational efficiency.
- Optimistic Outlook: UHS expects 2026 revenue to range between $18.4 billion and $18.8 billion, representing growth of 6% to 8%, and despite facing a $35 million negative impact from new California regulations, the company remains optimistic about future growth, emphasizing expense management and technology investments to address challenges.
See More
US Stocks Mostly Lower as Nvidia Earnings Fail to Boost Market Sentiment
- Market Weakness: The S&P 500 index fell by 0.74% and the Nasdaq 100 index dropped by 1.40%, indicating market concerns over Nvidia's earnings failing to alleviate worries about an overheated AI economy, which pressured chipmakers and AI infrastructure stocks.
- Nvidia Earnings Impact: Despite Nvidia reporting Q4 revenue of $62.3 billion, surpassing the consensus of $60.36 billion, its stock declined over 4% due to concerns regarding the Chinese market, reflecting investor doubts about demand durability.
- Salesforce Strong Performance: Salesforce shares rose more than 3%, leading software stocks higher after it provided a strong long-term sales outlook and announced a large share buyback, alleviating fears of AI disruption in the software sector.
- Geopolitical Risks Intensify: Ongoing nuclear talks between the US and Iran have heightened geopolitical risks, with President Trump threatening military action against Iran, which has further impacted investor sentiment and market stability.
See More
UNIVERSAL HEALTH SERVICES INC: UBS Increases Target Price from $302 to $320
- Price Increase Announcement: Universal Health Services has raised its target price from $302 to $320.
- Market Impact: This adjustment reflects the company's performance and expectations in the healthcare sector.
See More
Analysis & Outlook: Disappointed with Nvidia
- Market Reaction: Despite strong earnings from Nvidia, stocks experienced a decline.
- Investor Sentiment: The market's response indicates a disconnect between earnings reports and stock performance.
See More
US Stocks Close Mixed: Dow Rises Slightly, Nasdaq Declines
- Mixed Market Performance: On Thursday, the S&P 500 Index fell by 0.54% and the Nasdaq 100 Index declined by 1.16%, while the Dow Jones Industrial Average rose slightly by 0.03%, indicating a divergence in market sentiment, particularly under pressure from tech stocks.
- Nvidia Earnings Impact: Nvidia reported Q4 revenue of $62.3 billion, exceeding expectations, yet its stock dropped over 5% due to uncertainties regarding the Chinese market, reflecting investor concerns about an overheated AI economy that could affect related chipmakers' performance.
- Labor Market Signals: Initial jobless claims in the US rose by 4,000 to 212,000, lower than the expected 216,000, indicating resilience in the labor market, which may provide support for the stock market, especially amid potential interest rate cuts by the Fed.
- Geopolitical Risks Intensify: President Trump threatened military action against Iran, heightening market uncertainty; although there are signs of progress in US-Iran nuclear negotiations, geopolitical risks remain a focal point for investors and could negatively impact the stock market.
See More
U.S. Markets Closed with Mixed Results on Thursday, Driven by IonQ's Performance and Donaldson Co's Underperformance
- U.S. Stock Market Performance: U.S. stock indexes closed mixed on Thursday, with the S&P 500 gaining 0.03%.
- Decline in Other Indexes: The Dow Jones Industrial Average decreased by 0.54%, while the Nasdaq Composite fell by 1.18%.
See More
UHS Reports Strong Q4 2025 Earnings with Strategic Growth Plans
- Significant Revenue Growth: UHS reported a 9% revenue increase in Q4 2025, with adjusted EBITDA net of NCI rising 10% and adjusted EPS up 20%, reflecting strong performance in acute care and behavioral health, thereby enhancing market competitiveness.
- Clear Expansion Plans: The company plans to open three inpatient expansion projects totaling 178 licensed beds in Florida, California, and Nevada, along with a new 156-bed hospital in Palm Beach Gardens, Florida, set to open in Q2 2026, further enhancing service capacity.
- Accelerated Technology Investment: UHS has fully rolled out Agentic AI to improve post-discharge care and reduce readmissions, with plans to introduce new patient safety technologies in 2026, indicating a sustained commitment to technological innovation aimed at enhancing operational efficiency.
- Optimistic Outlook: UHS expects 2026 revenue to range between $18.4 billion and $18.8 billion, representing growth of 6% to 8%, and despite facing a $35 million negative impact from new California regulations, the company remains optimistic about future growth, emphasizing expense management and technology investments to address challenges.
See More
US Stocks Mostly Lower as Nvidia Earnings Fail to Boost Market Sentiment
- Market Weakness: The S&P 500 index fell by 0.74% and the Nasdaq 100 index dropped by 1.40%, indicating market concerns over Nvidia's earnings failing to alleviate worries about an overheated AI economy, which pressured chipmakers and AI infrastructure stocks.
- Nvidia Earnings Impact: Despite Nvidia reporting Q4 revenue of $62.3 billion, surpassing the consensus of $60.36 billion, its stock declined over 4% due to concerns regarding the Chinese market, reflecting investor doubts about demand durability.
- Salesforce Strong Performance: Salesforce shares rose more than 3%, leading software stocks higher after it provided a strong long-term sales outlook and announced a large share buyback, alleviating fears of AI disruption in the software sector.
- Geopolitical Risks Intensify: Ongoing nuclear talks between the US and Iran have heightened geopolitical risks, with President Trump threatening military action against Iran, which has further impacted investor sentiment and market stability.
See More
